Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2118 for Osteoporosis at ASBMR 2024
30 sept. 2024 07h30 HE
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
Angitia Biopharmaceuticals to Present Data on AGA2118 for Osteoporosis at ASBMR 2024
16 sept. 2024 07h30 HE
|
Angitia Biopharmaceuticals
Angitia announces multiple presentations at ASBMR.